secwatch.observer — SEC 8-K summary
======================================

Issuer:     GILEAD SCIENCES, INC. (GILD)
CIK:        0000882095
Form:       8-K
Filed at:   2021-10-28T23:59:59+00:00
Accession:  0000882095-21-000024
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Gilead Q3 GAAP EPS $2.05, revenue $7.4B; Biktarvy record $2.3B; raises FY guidance; redeems $1B notes
--------------------------------------------------------------------------------

- GAAP diluted EPS $2.05 vs $0.29 YoY; non-GAAP diluted EPS $2.65 vs $2.11 YoY.
- Total Q3 revenue $7.4B (+13% YoY); product sales ex-Veklury $5.4B (-3% YoY).
- Biktarvy sales record $2.3B (+20% YoY); Veklury sales $1.9B.
- FY 2021 guidance raised: total product sales $26.0-26.3B; non-GAAP EPS $7.90-8.10.
- Called $1B of 2023 notes (Floating Rate and 0.750% Senior Notes) for redemption on Nov 8, 2021.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/882095/000088209521000024/0000882095-21-000024-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/882095/000088209521000024/gild-20211028.htm
  HTML page:      https://secwatch.observer/filing/0000882095-21-000024

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer